6-Chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline is a quinoline-based compound used as a pharmaceutical intermediate. It is specifically employed in the synthesis of Bcr-Abl tyrosine kinase inhibitors, which are a key class of therapeutics for chronic myelogenous leukemia.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing 6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(R)-2-((4-aminophenethyl)amino)-1-phenylethanol
pharmaceutical intermediate
2-Chloro-3,5-dinitrobenzotrifluoride
pharmaceutical intermediate
N-Boc-3-methylamino piperidine
pharmaceutical intermediate
N'-(2-Cyano-4-nitrophenyl)-N,N-dimethylmethanimidamide
pharmaceutical intermediate
6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline
CXGFIHCGWHSIQO-UHFFFAOYSA-N
C1CC1C2=NC3=C(C=C(C=C3)Cl)C(=C2)C(F)(F)F
Sourcing 6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.